Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

GeorgeParros

Jun 22, 2020 07:06AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

BearDownAZ

Jun 22, 2020 07:39AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

BearDownAZ

Jun 22, 2020 08:32AM

dutchfella

Rank: Mail Room [?]

Points: 141 [?]

Votes: 15 Score: 2.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

in response to

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

BearDownAZ

posted on Jun 22, 2020 08:42AM

Given the FDA's wish list, it may be looking for 4000 patients but will likely settle for 3000 to 3500. RVX woud probably prefer 1500 to 2000.

Trial length should be 2 to 2.5 years from commencement.

Trial Cost should be in the range of $60 to 100 MM, depending on patient numbers of 2,000 to 4,000.

The Trail of Tears continues.

4 Recommendations

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

barsax

Jun 22, 2020 08:50AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

golfyeti

Jun 22, 2020 08:58AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

GeorgeParros

Jun 22, 2020 09:05AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Buckeyes

Jun 22, 2020 09:14AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

BearDownAZ

Jun 22, 2020 09:28AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

BearDownAZ

Jun 22, 2020 09:32AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

paladin

Jun 22, 2020 09:50AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Buckeyes

Jun 22, 2020 10:50AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

tada

Jun 22, 2020 12:02PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

RVXoldtimer

Jun 22, 2020 12:14PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

golfyeti

Jun 22, 2020 12:14PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

RVXoldtimer

Jun 22, 2020 12:26PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

tada

Jun 22, 2020 12:29PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

SanFrancisco99

Jun 22, 2020 01:18PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

fuzzyjr

Jun 22, 2020 01:36PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Toinv

Jun 22, 2020 05:45PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Toinv

Jun 22, 2020 05:54PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

tada

Jun 22, 2020 06:09PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Toinv

Jun 22, 2020 06:10PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Toinv

Jun 22, 2020 06:27PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Nextblockbuster

Jun 22, 2020 06:41PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Buckeyes

Jun 22, 2020 06:58PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

tada

Jun 22, 2020 08:46PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

tada

Jun 22, 2020 09:00PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

KOO-KOO2

Jun 22, 2020 10:15PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

barsax

Jun 22, 2020 10:42PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

tada

Jun 23, 2020 02:22AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study